| |
|
|
|
Derycz Scientific  
|
|
2.65 -0.02 (-0.01%) |
09-17 09:30 |
|
Open: |
2.61 |
Pre close: |
2.67 |
Target:
|
3.26
|
|
High: |
2.65 |
Low: |
2.65 |
Resistance:
|
2.79
3.26
|
|
Volume: |
63 |
Market Cap: |
71M |
Support:
|
2.52
2.35
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
2.60
 |
MACD |
MACD(12,26):
|
-0.00 |
|
MA(20): |
2.57 |
Signal(12,26,9): |
-0.01 |
|
MA(100): |
2.56 |
Stochastic Oscillator |
%K(14,3):
|
61.82 |
|
MA(250): |
2.42 |
%D(3): |
59.41  |
|
Average Volume(K) |
3-Month: |
279720
|
52-Week |
High:
|
3.26 |
|
10-Days: |
25810 |
Low: |
1.87 |
|
RSI |
RSI(14):
|
53.57 |
Change(%): |
16.6 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.009 |
Return on Equity (ttm) |
-4.0 |
Shares Out. (M) |
26.28 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-0.8 |
Shares Float (M) |
11.96 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
37.87 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
3.6 |
% Held by Institutions |
40.31 |
|
Forward EPS |
-0.040 |
Gross Profit (p.s.) |
0.367 |
Shares Short (K) |
44 |
|
Book Value (p.s.) |
0.200 |
EBITDA (p.s.) |
-0.007 |
P/E |
-296.67 |
|
Sales Per Share |
1.196 |
Qtrly Earnings Growth |
316.40 |
P/BV |
13.35 |
|
Profit Margin |
-0.63 |
Operating Cash Flow
(M) |
3.33 |
P/S |
2.23 |
|
Operating Margin |
-0.63 |
Levered Free Cash Flow
(M) |
3.50 |
P/CF |
21.07 |
|
|
|
|
|
|
